Fig. 4

Kaplan-Meier curves illustrating stratification of 5-Year OS by the AI iTIL score in Stage II clinical high risk cases (A), and Stage II pMMR clinical high and low risk cases (B) in each of the validation cohorts. Significant stratification, particularly in the pMMR clinical high risk group, suggests the AI iTIL score could be used as an additional signal to identify patients with better/worse outcomes